Who recommends a pair of drugs to fight corona

Highlights

  • After Delta, this time Omicron is suffering the whole world.
  • The World Health Organization (WHO) has also questioned the use of two special drugs to treat Omicron.
  • Hu claims that these two drugs will cost less than the equivalent of current drugs.

This time: After Delta, this time Omicron is suffering the whole world. This new hyper-infectious variant of Corona is gradually gaining ground. The World Health Organization (WHO) estimates that more than half of Europe’s population will be infected by Omicron by March. But whether the variant is the Delta or the Omicron, Corona has long been said to be the most powerful tool in war. The World Health Organization (WHO) has also questioned the use of two special drugs to treat Omicron. Hu claims that these two drugs will cost less than the equivalent of current drugs. But there will be no difference in effectiveness.

Baricitinib is one of the two newly recommended drugs. The second is Sotrovimab. Baricitinib is mainly used in the treatment of rheumatoid arthritis. However, from now on, this drug can be used in the treatment of severe or critical corona patients, according to recent guidelines. Baricitinib is much cheaper in price than drugs like interleukin-6 receptor blockers, such as Tosilizumab or Cerilumab, which are commonly used to treat cytokine storms. However, it is recommended to use steroids along with it to get the expected results. However, for those who are having spinal problems after being infected with Kovid (now mainly Omicron), Baricitinib may be more effective because of its anti-arthritic character.

Colds protected by colds!

According to some experts, the use of this drug with complete vaccination will be able to prevent serious illness or death. In a recent report published in the British Medical Journal, Hu’s specialist doctors claimed that the combined use of corticosteroids and baricitinib in critically ill patients with coronary heart disease greatly reduced the risk of ventilation and death. Earlier, Hu had recommended Tosilizumab and Sarilumab, which are used in the treatment of arthritis, for corona treatment. The company also approved the use of corticosteroids. Of the three, the type of baricitinib is slightly different but more effective for critically ill patients, Hu said.

Experts on Sotrovimab claim that the drug can be used in patients with relatively stable or mild to moderate corona symptoms. In order to avoid such patients being admitted to the hospital, at least a lot can be reduced. Sotrovimab is basically a synthetic monoclonal antibody therapy. But using Sotrovimab at a lower cost than the combination of Casirimivab and Imdemivab currently used as a monoclonal antibody cocktail therapy.

eisamayDo not prevent nasal spray! Claim scientists

The drug is recommended for early treatment in patients at risk, mainly due to age or co-morbidity. Because, when such patients become seriously ill, a large part of them in the hospital, their health deteriorates. To prevent this from happening, Hu recommends using Sotrovimab.

Recently, Hu-i reported that with the onset of winter, the risk of coronary heart disease and various respiratory diseases is likely to increase. There are also fears of the flu becoming more severe in different parts of the world. In that context, a section of the medical community thinks that the recommendation of two new drugs to deal with corona is very significant. However, the World Health Organization has made it clear that neither of the two drugs is suitable for use in all cases. Which means it’s about to be the most delusional time of the year, as well.

ei samay

Symbolic image

We would love to give thanks to the writer of this article for this incredible web content

Who recommends a pair of drugs to fight corona

Wyomingnetworknews.com